Pfizer

Featured

Despite compulsory licensing, generic cancer drug too costly for the poor
- Nirmalya Dutta
March 21, 2012 at 09:18am
Despite the ruling earlier this week that allowed Natco, an Indian pharmacy to copy Bayer’s Nexavar, a blockbuster cancer drug that will bring …

more articles...

Recent Questions

more questions...

Ask an expert

You agree to the terms and conditions by posting your question

Post question anonymously (Your name would not be displayed on screen)

News

more news...